| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |